Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 90 results found. Search for [ ICMR advisory ]

Results 1 to 21 of 90
June 25, 2021
Highlighting that there is still no concern for the third wave of COVID-19, Dr Sumit Aggarwal, Scientist and Program Officer, Division of Epidemiology and Communicable disease, ICMR, said it's too early to predict the third wave as it depends on many other factors

June 16, 2021
\"Symptomatic cases were significantly higher at 28.7 per cent in the second wave (111/387), compared to the first wave (162/1143) when the proportion was 14.2 per cent,\" the apex research body said

May 20, 2021
Advisory highlights important role masks, distance, sanitation, and well-ventilated spaces play in diluting viral load of infected air in poorly ventilated houses and offices

May 20, 2021
Self-use kit is named CoviSelf and priced at Rs 250 per pack. Self-use test can only be used by symptomatic individuals and those who come in contact with lab-tested Covid-19 people

Joe C Mathew
May 20, 2021
Named CoviSelf, the self-use test can be used by symptomatic individuals and immediate contacts of confirmed cases as per ICMR guidelines without the need for sample collection by a healthcare professional

May 15, 2021
In a meeting of the ICMR-National Task Force for COVID-19, all members were in favour of removing the use of convalescent plasma from the Clinical Guidance for Management of Adult COVID-19 Patients.

May 12, 2021
The government said that it is engaging with manufacturers to ramp up production of the drug. Supply of Amphotericin B will be improved through an increase in production and extra imports

May 9, 2021
Sinuses or lungs of individuals suffering from the disease get affected after fungal spores are inhaled from the air. \"Mucormycosis - if uncared for - may turn fatal,\" it added.

May 5, 2021
Despite the warning, scientists said the federal government did not seek to impose major restrictions to stop the spread of the virus

Chitranjan Kumar
November 30, 2020
Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe

PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

September 11, 2020
As per the order, the price of COVID-19 confirmatory test through TrueNat was also fixed at Rs 1,600

September 6, 2020
A letter jointly written by Union Health Secretary Rajesh Bhushan and ICMR Director General Dr Balram Bhargava to chief secretaries and administrators highlighted that having adequate testing capacities and simplified testing protocol are important components of COVID-19 management

September 5, 2020
The Indian Council of Medical Research (ICMR) on Friday issued a new advisory on COVID-19 testing strategy, allowing 'testing on demand' for individuals but left it to the states to modify the approach as per their discretion

July 31, 2020
Coronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workers

July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles

July 15, 2020
Stock Market Highlights on July 15: Infosys, Axis Bank, Tech Mahindra, Bajaj Finance, Tata Steel, HCL Tech and IndusInd Bank were among the other gainers on Sensex. On the other hand, Bharti Airtel, ITC and Kotak Bank were the laggards

July 7, 2020
Earlier, it had advised all COVID-19 hospitals to opt for \"prone awake ventilation\" as and when possible before putting a patient on conventional mechanical ventilation

E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021

June 5, 2020
The observational study published in the Lancet on May 22 said it looked at 96,000 hospitalized COVID-19 patients, some treated with the decades-old malaria drug

PAGES 1 OF 5  12345